{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:15Z","timestamp":1761519015868},"reference-count":28,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.clinthera.2011.08.015","type":"journal-article","created":{"date-parts":[[2011,9,29]],"date-time":"2011-09-29T12:08:23Z","timestamp":1317298103000},"page":"1357-1364","source":"Crossref","is-referenced-by-count":7,"title":["Efficacy and Tolerability of a New Extended-Release Formulation of Nicotinic Acid in Korean Adults With Mixed Dyslipidemia: An 8-Week, Multicenter, Prospective, Randomized, Double-Blind, and Placebo-Controlled Trial"],"prefix":"10.1016","volume":"33","author":[{"given":"Sang-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Jae","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2011.08.015_bib1","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2011.08.015_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","article-title":"High density lipoprotein as a protective factor against coronary heart disease","volume":"62","author":"Gordon","year":"1977","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2011.08.015_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/diacare.28.1.101","article-title":"Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?","volume":"28","author":"Drexel","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2011.08.015_bib4","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/01.ATV.13.12.1728","article-title":"Familial hypoalphalipoproteinemia in premature coronary artery disease","volume":"13","author":"Genest","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.clinthera.2011.08.015_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1161\/01.ATV.17.1.95","article-title":"Effects of serum lipoproteins and smoking on atherosclerosis in young men and women","volume":"17","author":"McGill","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinthera.2011.08.015_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jc.86.3.965","article-title":"Clinical review 124: Diabetic dyslipidemia: causes and consequences","volume":"86","author":"Goldberg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2011.08.015_bib7","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1210\/jc.2004-0305","article-title":"Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity","volume":"89","author":"Hansel","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2011.08.015_bib8","series-title":"The Fourth Korea National Health and Nutrition Examination Survey (KHANES IV-1), 2007","year":"2008"},{"key":"10.1016\/j.clinthera.2011.08.015_bib9","series-title":"The Third Korea National Health and Nutrition Examination Survey (KHANES III), 2005","year":"2007"},{"key":"10.1016\/j.clinthera.2011.08.015_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"issue":"Suppl F","key":"10.1016\/j.clinthera.2011.08.015_bib11","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1093\/eurheartj\/sul036","article-title":"Epidemiology of low HDL-cholesterol: results of studies and surveys","volume":"8","author":"Bruckert","year":"2006","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.clinthera.2011.08.015_bib12","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mhj.2000.110090","article-title":"Effective and safe modification of multiple atherosclerotic risk factors in patients with peripheral arterial disease","volume":"140","author":"Garg","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2011.08.015_bib13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1517\/14656566.5.6.1385","article-title":"Extended-release niacin for modifying the lipoprotein profile","volume":"5","author":"Guyton","year":"2004","journal-title":"Expert Opin Pharmacother"},{"issue":"Suppl F","key":"10.1016\/j.clinthera.2011.08.015_bib14","doi-asserted-by":"crossref","first-page":"F41","DOI":"10.1093\/eurheartj\/sui042","article-title":"Niaspan: creating a new concept for raising HDL-cholesterol","volume":"7","author":"McGovern","year":"2005","journal-title":"Eur Heart J Suppl"},{"issue":"Suppl F","key":"10.1016\/j.clinthera.2011.08.015_bib15","doi-asserted-by":"crossref","first-page":"F60","DOI":"10.1093\/eurheartj\/sul043","article-title":"Niaspan in the management of dyslipidaemia: the evidence","volume":"8","author":"Brown","year":"2006","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.clinthera.2011.08.015_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2004.10.031","article-title":"Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials","volume":"45","author":"Birjmohun","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2011.08.015_bib18","series-title":"Medical Statistics: A Textbook for the Health Sciences","author":"Campbell","year":"2007"},{"key":"10.1016\/j.clinthera.2011.08.015_bib19","doi-asserted-by":"crossref","first-page":"29U","DOI":"10.1016\/S0002-9149(98)00732-2","article-title":"A new, extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients","volume":"82","author":"Morgan","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.08.015_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1001\/archinte.160.8.1177","article-title":"Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol: Niaspan-Gemfibrozil Study Group","volume":"160","author":"Guyton","year":"2000","journal-title":"Arch Intern Med"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2011.08.015_bib21","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/0021-9150(94)90152-X","article-title":"Familial lipoprotein disorders and premature coronary artery disease","volume":"108","author":"Schaefer","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinthera.2011.08.015_bib22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0002-9149(98)00448-2","article-title":"Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia","volume":"82","author":"Guyton","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.08.015_bib23","doi-asserted-by":"crossref","first-page":"22C","DOI":"10.1016\/j.amjcard.2006.11.018","article-title":"Safety considerations with niacin therapy","volume":"99","author":"Guyton","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.08.015_bib24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-9149(97)01016-3","article-title":"Effects of crystalline nicotinic acid\u2013induced hepatic dysfunction on serum low-density lipoprotein cholesterol and lecithin cholesteryl acyl transferase","volume":"81","author":"Tat\u00f2","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2011.08.015_bib25","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jama.264.6.723","article-title":"Nicotinic acid as therapy for dyslipidemia in non\u2013insulin-dependent diabetes mellitus","volume":"264","author":"Garg","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.08.015_bib26","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jama.284.10.1263","article-title":"Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial","volume":"284","author":"Elam","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2011.08.015_bib27","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/archinte.162.14.1568","article-title":"Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial","volume":"162","author":"Grundy","year":"2002","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2011.08.015_bib28","first-page":"S68","article-title":"Dyslipidaemia management in adults with diabetes","volume":"27","author":"Haffner","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2011.08.015_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4082\/kjfm.2011.32.3.173","article-title":"Gender difference in the level of HDL cholesterol in Korean adults","volume":"32","author":"Kim","year":"2011","journal-title":"Korean J Fam Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811005546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291811005546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T20:28:21Z","timestamp":1543523301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291811005546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":28,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0149291811005546"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2011.08.015","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}